Influenza A H1N1 Neuraminidase Antibody Sino

H1N1 Neuraminidase Antibody
24923-100ul 100ul
EUR 468

Human IgG antibody Laboratories manufactures the influenza a h1n1 neuraminidase antibody sino reagents distributed by Genprice. The Influenza A H1N1 Neuraminidase Antibody Sino reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza Antibody. Other Influenza products are available in stock. Specificity: Influenza Category: A Group: H1N1 Neuraminidase

Seasonal H1N1 Neuraminidase Antibody
100ul
EUR 479

Seasonal H1N1 Neuraminidase Antibody
100ul
EUR 468

Swine H1N1 Neuraminidase Antibody
100ul
EUR 479

Swine H1N1 Neuraminidase Antibody
100ul
EUR 468

Seasonal H1N1 Neuraminidase Antibody
0.02 mg
EUR 206.18
Description: Seasonal H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Seasonal H1N1 Neuraminidase Antibody
0.1 mg
EUR 523.7
Description: Seasonal H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Swine H1N1 Neuraminidase Antibody
0.02 mg
EUR 206.18
Description: Swine H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

H1N1 Neuraminidase information

Influenza A H5N1 Neuraminidase
MBS318535-005mg 0.05mg
EUR 400

Influenza A H5N1 Neuraminidase
MBS318535-5x005mg 5x0.05mg
EUR 1635

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (AP)
MBS6481621-01mL 0.1mL
EUR 1135

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (AP)
MBS6481621-5x01mL 5x0.1mL
EUR 4955

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (PE)
MBS6481631-01mL 0.1mL
EUR 1135

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (PE)
MBS6481631-5x01mL 5x0.1mL
EUR 4955

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (APC)
MBS6481622-01mL 0.1mL
EUR 1135

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (APC)
MBS6481622-5x01mL 5x0.1mL
EUR 4955

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (HRP)
MBS6481625-01mL 0.1mL
EUR 1135

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (HRP)
MBS6481625-5x01mL 5x0.1mL
EUR 4955

Polyclonal Avian Influenza A H7N9 Neuraminidase Antibody
APR10997G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza A H7N9 Neuraminidase . This antibody is tested and proven to work in the following applications:

Polyclonal Avian Influenza A H7N9 Neuraminidase Antibody
APR10998G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza A H7N9 Neuraminidase . This antibody is tested and proven to work in the following applications:

Polyclonal Avian Influenza A H7N9 Neuraminidase Antibody
APR10999G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza A H7N9 Neuraminidase . This antibody is tested and proven to work in the following applications:

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (FITC)
MBS6481624-01mL 0.1mL
EUR 1135

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (FITC)
MBS6481624-5x01mL 5x0.1mL
EUR 4955

Rabbit Anti Influenza A Neuraminidase (H1N1-NA) antiserum
H1N1NA11-S 100 ul
EUR 548.4

Influenza A Neuraminidase N1 (A/Georgia/20/2006) (H1N1) (Biotin)
MBS6481623-01mL 0.1mL
EUR 1135